During the past decade, Canterbury Urology Research Trust conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canterbury Urology Research Trust" #1 sponsor was "Abbott" with 2 trials, followed by "Bayer" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "University of Sydney" with 2 trials sponsored and "Noxopharm Limited" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canterbury Urology Research Trust" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator, "Cancer Australia" with 1 trials as a collaborator, "Cancer Council New South Wales" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Canterbury Urology Research Trust" are "Cancer" (2 trials), "Prostatic Neoplasms" (2 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Canterbury Urology Research Trust" in a lesser frequency.

Most popular intervention types in "Canterbury Urology Research Trust" are "Drug" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atrasentan" (2 trials), "Abiraterone acetate (AA)" (1 trials), "Androgen deprivation therapy (ADT)" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canterbury Urology Research Trust" are 6 trials for "Male" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Canterbury Urology Research Trust". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Canterbury Urology Research Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Canterbury Urology Research Trust, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".